Process map proposal for the validation of genomic biomarkers

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.5, 2006-07, pp. : 773-782

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease

Current Drug Metabolism, Vol. 15, Iss. 2, 2014-02 ,pp. : 129-181

Bentham Science Publishers

Access to resources Recommend Favorite

Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling

By Colburn W.A.

Clinical Pharmacokinetics, Vol. 42, Iss. 12, 2003-01 ,pp. : 997-1022

Adis International

Access to resources Recommend Favorite

Genomic-based biomarkers of drug-induced nephrotoxicity

By Davis John W Kramer Jeffrey A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 95-101

Informa Healthcare

Access to resources Recommend Favorite

Genomic biomarkers, androgen pathway and prostate cancer

By D’’Amico Franca Biancolella Michela Margiotti Katia Reichardt Juergen KV Novelli Giuseppe

Pharmacogenomics, Vol. 8, Iss. 6, 2007-06 ,pp. : 645-661

Future Medicine

Access to resources Recommend Favorite

Identifying Biomarkers of Lung Cancer in the Post-Genomic Era

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-12 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite